VAERS reports by lot

Moderna COVID-19 lot 03L20A: VAERS reports

57 VAERS reports list lot 03L20A as a Moderna COVID-19 vaccine, received between 2021-01-15 and 2022-05-12. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
57
Reports
4%
Marked serious
1
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)4321%
Injection-site / Local reaction3819%
Musculoskeletal2613%
Gastrointestinal2412%
Neurological199%
Cardiac / Cardiovascular157%
Dermatological (non-injection-site)157%
Respiratory84%
Allergic / Anaphylactic73%
Thrombotic / Hematological31%
Reproductive / Menstrual21%
Psychiatric / Neuropsychiatric10%

Where reports came from

U.S. state of the reporter, where given (top 12).

Kentucky5
Pennsylvania5
Virginia5
Puerto Rico4
Indiana3
New Jersey3
Arizona3
Montana2
Florida2
Iowa2
Wisconsin2
Oklahoma2

Reports by month received

2021-0116
2021-0215
2021-033
2021-062
2021-0816
2021-101
2021-121
2022-011
2022-021
2022-051

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.